Literature DB >> 19801921

Clinical outcome of surgical treatment for periorbital basal cell carcinoma.

Natsuko Kakudo1, Yutaka Ogawa, Kenji Suzuki, Satoshi Kushida, Kenji Kusumoto.   

Abstract

Basal cell carcinoma (BCC) has a predilection for the periorbital region, which is a special, prominent, cosmetic, functional area to protect the eyeball. For squamous cell carcinoma and melanoma, extensive resection with reconstruction is performed. In contrast, for BCC, resection is often confined to a small to medium-sized area, necessitating higher-quality reconstructive surgery. We analyze the surgical outcomes of treatment for periorbital BCC, and evaluate reconstruction method after resection. Forty-nine patients with periorbital BCC had surgery in our hospital over 20 years. Age, gender of the patients, and size, localization, and histology of the tumor, and surgical procedures, and their early and late complications were analyzed retrospectively. BCC was most frequently occurred in the lower lid (55%), followed by inner canthus (19%), upper lid (17%), and outer canthus (9%). The histologic classifications were solid (80%), morphea (7%), mix (7%), superficial (2%), keratotic (2%), and adenoid (2%). Recurrence of the tumor was observed in 2 advanced cases in patients treated with resection of the tumor including surrounding tissue 5 mm from the margin. A rotation advancement cheek flap procedure was most frequently applied. Horizontal shift of the skin was most effective to prevent postoperative lagophthalmos. BCC occurred most frequently in the lower lid within the periorbital area. Rotation advancement of cheek flap with horizontal shift of the skin is most effective procedure in both appearance and function of the eyelid.

Entities:  

Mesh:

Year:  2009        PMID: 19801921     DOI: 10.1097/SAP.0b013e3181953a5e

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  Cheek rotation flap reconstruction--an anthropometric appraisal of surgical outcomes.

Authors:  Gregor F Raschke; Ulrich M Rieger; Rolf-Dieter Bader; Arndt Guentsch; Oliver Schaefer; Stefan Elstner; Stefan Schultze-Mosgau
Journal:  Clin Oral Investig       Date:  2013-08-07       Impact factor: 3.573

2.  Superpulsed CO 2 Laser with Intraoperative Pathologic Assessment for Treatment of Periorbital Basal Cell Carcinoma Involving Eyelash Line.

Authors:  Ali Ebrahimi; Mansour Rezaei; Reza Kavoussi; Mojtaba Eidizadeh; Seyed Hamid Madani; Hossein Kavoussi
Journal:  Dermatol Res Pract       Date:  2014-10-13

Review 3.  Management of high-risk and advanced basal cell carcinoma.

Authors:  S Puig; A Berrocal
Journal:  Clin Transl Oncol       Date:  2015-02-03       Impact factor: 3.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.